Drugs / YY-351
last change Jun 2009 re-read 3 minutes ago

YY-351

Developed for
diabetes mellitus
Investigated by
Yuyu Pharma, Inc.

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01008163 Jan 2008 → Jun 2009 diabetes mellitus Yuyu Pharma, Inc. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as YY-351 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01008163 ↗
Route Oral “YY-351, PO, 1T tid.” NCT01008163 ↗